Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1989 1
1991 1
1992 1
1993 5
1994 3
1995 4
1996 2
1997 5
1998 3
1999 4
2000 3
2002 1
2003 1
2004 6
2005 6
2006 9
2007 4
2008 5
2009 10
2010 12
2011 6
2012 6
2013 11
2014 9
2015 9
2016 5
2017 7
2018 8
2019 22
2020 30
2021 19
2022 15
Text availability
Article attribute
Article type
Publication date

Search Results

209 results
Results by year
Filters applied: . Clear all
Page 1
Intracellular Edema.
Narayanan R, Kuppermann BD. Narayanan R, et al. Among authors: kuppermann bd. Dev Ophthalmol. 2017;58:21-26. doi: 10.1159/000455266. Epub 2017 Mar 28. Dev Ophthalmol. 2017. PMID: 28351042 Review.
Brolucizumab and immunogenicity.
Sharma A, Kumar N, Parachuri N, Sharma R, Bandello F, Kuppermann BD, Loewenstein A. Sharma A, et al. Among authors: kuppermann bd. Eye (Lond). 2020 Oct;34(10):1726-1728. doi: 10.1038/s41433-020-0853-9. Epub 2020 Apr 6. Eye (Lond). 2020. PMID: 32251366 Free PMC article. No abstract available.
Brolucizumab: the road ahead.
Sharma A, Kumar N, Bandello F, Kuppermann BD, Loewenstein A, Regillo CD. Sharma A, et al. Among authors: kuppermann bd. Br J Ophthalmol. 2020 Dec;104(12):1631-1632. doi: 10.1136/bjophthalmol-2020-317528. Epub 2020 Aug 22. Br J Ophthalmol. 2020. PMID: 32829303 No abstract available.
Biosimilars for Retinal Diseases: An Update.
Sharma A, Kumar N, Parachuri N, Bandello F, Kuppermann BD, Loewenstein A. Sharma A, et al. Among authors: kuppermann bd. Am J Ophthalmol. 2021 Apr;224:36-42. doi: 10.1016/j.ajo.2020.11.017. Epub 2020 Dec 9. Am J Ophthalmol. 2021. PMID: 33309691 Review.
Brolucizumab-foreseeable workflow in the current scenario.
Sharma A, Kumar N, Parachuri N, Kuppermann BD, Bandello F, Regillo CD, Boyer D, Nguyen QD. Sharma A, et al. Among authors: kuppermann bd. Eye (Lond). 2021 Jun;35(6):1548-1550. doi: 10.1038/s41433-020-01324-w. Epub 2021 Feb 2. Eye (Lond). 2021. PMID: 33531697 Free PMC article. No abstract available.
Ranibizumab.
Narayanan R, Kuppermann BD, Jones C, Kirkpatrick P. Narayanan R, et al. Among authors: kuppermann bd. Nat Rev Drug Discov. 2006 Oct;5(10):815-6. doi: 10.1038/nrd2157. Nat Rev Drug Discov. 2006. PMID: 17078173 No abstract available.
Hot Topics in Dry AMD.
Narayanan R, Kuppermann BD. Narayanan R, et al. Among authors: kuppermann bd. Curr Pharm Des. 2017;23(4):542-546. doi: 10.2174/1381612822666161221154424. Curr Pharm Des. 2017. PMID: 28003009 Review.
Brolucizumab-another anti-VEGF or beyond.
Sharma A, Parachuri N, Kumar N, Sharma R, Bandello F, Kuppermann BD, Loewenstein A. Sharma A, et al. Among authors: kuppermann bd. Eye (Lond). 2020 Sep;34(9):1499-1500. doi: 10.1038/s41433-020-0888-y. Epub 2020 Apr 21. Eye (Lond). 2020. PMID: 32317791 Free PMC article. No abstract available.
Immune recovery uveitis.
Kuppermann BD, Holland GN. Kuppermann BD, et al. Am J Ophthalmol. 2000 Jul;130(1):103-6. doi: 10.1016/s0002-9394(00)00537-7. Am J Ophthalmol. 2000. PMID: 11004267 Review. No abstract available.
209 results